New York State Common Retirement Fund’s Forte Biosciences FBRX Stock Holding History

New York State Common Retirement Fund’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Buy	+6,800	New	+$161K	﹤0.01%	2506
2022 Q3	–	Sell	-4	Closed	–	–	3332
2022 Q2	$0	Sell	4 -384	-99%	-$12.2K	﹤0.01%	3496
2022 Q1	$14K	Sell	388 -5	-1%	-$189	﹤0.01%	3304
2021 Q4	$21K	Hold	393	–	–	﹤0.01%	3295
2021 Q3	$29K	Buy	393 +5	+1%	+$2.77K	﹤0.01%	3281
2021 Q2	$326K	Buy	+388	New	+$350K	﹤0.01%	2807
2020 Q2	–	Sell	-46	Closed	-$21K	–	3237
2020 Q1	$21K	Hold	46	–	–	﹤0.01%	3101
2019 Q4	$9K	Hold	46	–	–	﹤0.01%	3193
2019 Q3	$11K	Hold	46	–	–	﹤0.01%	3213
2019 Q2	$115K	Hold	46	–	–	﹤0.01%	3048
2019 Q1	$187K	Hold	46	–	–	﹤0.01%	2747
2018 Q4	$141K	Hold	46	–	–	﹤0.01%	2846
2018 Q3	$268K	Hold	46	–	–	﹤0.01%	2699
2018 Q2	$161K	Hold	46	–	–	﹤0.01%	2975
2018 Q1	$204K	Hold	46	–	–	﹤0.01%	2723
2017 Q4	$176K	Buy	46 +22	+92%	+$87.8K	﹤0.01%	2812
2017 Q3	$112K	Hold	24	–	–	﹤0.01%	2984
2017 Q2	$108K	Buy	+24	New	+$135K	﹤0.01%	3075

Other funds holding FBRX

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

New York State Common Retirement Fund's FBRX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Forte Biosciences (FBRX) in Q2 2026: 6,800 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #2506 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in FBRX as recently as Q2 2022.

New York State Common Retirement Fund first reported a position in FBRX in Q2 2017 and has held it in 18 quarters since. The position peaked at $326K in Q2 2021. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

New York State Common Retirement Fund held 6,800 shares of Forte Biosciences worth $145K as of Q2 2026.
Forte Biosciences was a new New York State Common Retirement Fund position in Q2 2026.
Forte Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2506 holding.
New York State Common Retirement Fund first reported a position in Forte Biosciences in Q2 2017 and has held it in 18 quarters since.
New York State Common Retirement Fund's Forte Biosciences position peaked at $326K in Q2 2021.
86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.